1. Home
  2. GOSS vs ORN Comparison

GOSS vs ORN Comparison

Compare GOSS & ORN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GOSS
  • ORN
  • Stock Information
  • Founded
  • GOSS 2015
  • ORN 1994
  • Country
  • GOSS United States
  • ORN United States
  • Employees
  • GOSS N/A
  • ORN N/A
  • Industry
  • GOSS Biotechnology: Pharmaceutical Preparations
  • ORN Military/Government/Technical
  • Sector
  • GOSS Health Care
  • ORN Industrials
  • Exchange
  • GOSS Nasdaq
  • ORN Nasdaq
  • Market Cap
  • GOSS 347.8M
  • ORN 339.4M
  • IPO Year
  • GOSS 2019
  • ORN 2007
  • Fundamental
  • Price
  • GOSS $1.84
  • ORN $9.30
  • Analyst Decision
  • GOSS Strong Buy
  • ORN Strong Buy
  • Analyst Count
  • GOSS 4
  • ORN 2
  • Target Price
  • GOSS $8.25
  • ORN $11.25
  • AVG Volume (30 Days)
  • GOSS 3.6M
  • ORN 362.9K
  • Earning Date
  • GOSS 08-11-2025
  • ORN 07-29-2025
  • Dividend Yield
  • GOSS N/A
  • ORN N/A
  • EPS Growth
  • GOSS N/A
  • ORN N/A
  • EPS
  • GOSS N/A
  • ORN 0.08
  • Revenue
  • GOSS $124,590,000.00
  • ORN $824,375,000.00
  • Revenue This Year
  • GOSS N/A
  • ORN $4.34
  • Revenue Next Year
  • GOSS $65.50
  • ORN $11.09
  • P/E Ratio
  • GOSS N/A
  • ORN $117.42
  • Revenue Growth
  • GOSS N/A
  • ORN 15.58
  • 52 Week Low
  • GOSS $0.66
  • ORN $4.64
  • 52 Week High
  • GOSS $1.94
  • ORN $9.64
  • Technical
  • Relative Strength Index (RSI)
  • GOSS 70.54
  • ORN 61.78
  • Support Level
  • GOSS $1.67
  • ORN $8.14
  • Resistance Level
  • GOSS $1.94
  • ORN $8.79
  • Average True Range (ATR)
  • GOSS 0.14
  • ORN 0.32
  • MACD
  • GOSS 0.04
  • ORN 0.01
  • Stochastic Oscillator
  • GOSS 86.81
  • ORN 96.03

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

About ORN Orion Group Holdings Inc. Common

Orion Group Holdings Inc is a specialty construction company serving the infrastructure, industrial, and building sectors, providing services both on and off the water in the continental United States, Alaska, Canada and the Caribbean Basin through its marine segment and its concrete segment. Its marine segment provides construction and dredging services relating to marine transportation facility construction, marine pipeline construction, marine environmental structures, dredging of waterways, channels and ports, environmental dredging, design, and specialty services. Its concrete segment provides turnkey concrete construction services including pour and finish, dirt work, layout, forming, rebar and mesh across the light commercial, structural and other associated business areas.

Share on Social Networks: